Search

everythinglearnresearchcommunity

for

Search:↓

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Spironolactone works well for acne and hirsutism, isotretinoin is very effective for acne and may have antiandrogenic effects, and 5 alpha-reductase inhibitors should be considered antiandrogens.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.